Home > Publications >Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses >

<<Previous Next>>

Post Date:Feb-08-22

Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses

AcceGenAuthor: AcceGen R&D Team

Date Published: 08-Feb-22

Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses

  • Authors: Steven S. Good, Ashleigh Shannon, Kai Lin, Adel Moussa, Justin G. Julander, Paolo La Colla, Gabriella Collu, Bruno Canard, Jean-Pierre Sommadossi
  • Journal: Antimicrobial Agents and Chemotherapy
  • DOI: 10.1128/AAC.00988-21
  • Cited AcceGen Product/Service: Huh-7

<<Previous Next>>

AcceGen Scroll Top Button